JACOMO: what changed
Position among the sector peers
Sector benchmark: create a free account or sign in to use this tool.
You see every sector peer as a dot per ratio, with the company in two financial years and every ratio over five years against the sector.
What moved between 2024 and 2025
Largest movements
No asset line moved by more than 1% of the balance sheet total.
- Profit (loss) carried forward -€671
down €671 (-2.0%), from -€33,650 to -€34,321
- Trade debts +€671
up €671 (+50.1%), from €1,337 to €2,008
- Gross operating margin +€44
up €44 (+6.2%), from -€715 to -€671
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
Cash or the result is not a separate line in both sets of accounts. So the cash flow cannot be derived from them.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Equity | 10/15 | -€9,400 | -€10,071 | -€671 | -7.1% |
| Contributions | 10/11 | €18,750 | €18,750 | = | 0.0% |
| Reserves | 13 | €5,500 | €5,500 | = | 0.0% |
| Tax-exempt reserves | 132 | €5,500 | €5,500 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€33,650 | -€34,321 | -€671 | -2.0% |
| Amounts payable | 17/49 | €9,400 | €10,071 | +€671 | +7.1% |
| Amounts payable within one year | 42/48 | €9,400 | €10,071 | +€671 | +7.1% |
| Trade debts | 44 | €1,337 | €2,008 | +€671 | +50.1% |
| Suppliers | 440/4 | €1,337 | €2,008 | +€671 | +50.1% |
| Other amounts payable | 47/48 | €8,062 | €8,062 | = | 0.0% |
| Gross operating margin | 9900 | -€715 | -€671 | +€44 | +6.2% |
| Operating profit (loss) | 9901 | -€715 | -€671 | +€44 | +6.2% |
| Profit (loss) for the period before taxes | 9903 | -€715 | -€671 | +€44 | +6.2% |
| Profit (loss) for the period | 9904 | -€715 | -€671 | +€44 | +6.2% |
| Profit (loss) for the period to be appropriated | 9905 | -€715 | -€671 | +€44 | +6.2% |
Value
latest balance sheet 31-12-2025 · indication, not a valuation or adviceIndicative value of the equity
Indication, not a valuation or adviceMidpoint €0 · adjusted equity only
Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50% revaluation €0 other adjustment €0 EBITDA multiple
The filed figures and these assumptions give no positive value. The adjusted equity and the average result are both zero or negative.
Part of the calculation comes out below zero. A shareholding is never worth less than zero, so the floor is zero.
Adjusted equity
- Equity (10/15)
- -€10,071
- Formation expenses (20)
- €0
- Intangible fixed assets (21)
- €0
- Revaluation of assets
- €0
- Deferred tax on the revaluation
- €0
- Other adjustment
- €0
- Adjusted equity
- -€10,071
Capitalised earnings
- 2025
- -€671
- 2024
- -€715
- 2023
- -€799
- 2022
- -€1,532
- 2021
- -€2,410
- Average result, excluding non-recurring income and charges
- -€728
- Divided by the capitalisation rate
- 14% / 12% / 10%
- Capitalised earnings
- not meaningful, as the average result is zero or negative
Your EBITDA multiple
- EBITDA 2025
- -
- Net financial debt
- -
- Your multiple
- -
- Value with your multiple
- -
These accounts do not break down the debts after one year. They count in full as financial debt.
Limits of the indication
- Checked holds no market prices or comparable transactions.
- Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
- Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
- The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.
For a valuation to base a decision on, go to a company auditor or a certified accountant.
Next steps
Calculation and sources
Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 13 November 2026 via checked.be.